Daniel Robert Fandrick
6Patents
2h-index
34Co-inventors
47Inventor score
Filing activity: Sep 22, 2009 → Jan 10, 2019
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7879873B2 | Azaindazole compounds as CCR1 receptor antagonists | Human Necessities | 15 | Active |
| US9845314B2 | Pyrazolyl-substituted heteroaryls and their use as medicaments | Emerging Cross-Sectional Technologies | 2 | Active |
| US10544177B2 | Chiral dihydrobenzooxaphosphole ligands and synthesis thereof | Chemistry; Metallurgy | 0 | Active |
| US8916701B2 | Methods of making diastereomeric organic compounds | Chemistry; Metallurgy | 0 | Active |
| US10155751B2 | Pyrazolyl-substituted heteroaryls and their use as medicaments | Emerging Cross-Sectional Technologies | 0 | Active |
| US10221203B2 | Chiral dihydrobenzooxaphosphole ligands and synthesis thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.